Recruiting

Endoscopic Bariatric Therapies

Sponsor:

Weill Medical College of Cornell University

Code:

NCT04494048

Conditions

Obesity

Weight Loss

Gastro Esophageal Reflux

Bariatric Surgery Candidate

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Endoscopic Bariatric Therapies

Study Details

Brief summary:

The purpose of this registry study is to collect data through medical chart review and in patient visits on the efficacy and safety of various Endoscopic Bariatric therapies (EBTs). This is a retrospective and prospective, observational, medical chart review study for at least 6 standard of care visits up to 1 years after a subject consents for study participation.

Conditions

Obesity

Weight Loss

Gastro Esophageal Reflux

Bariatric Surgery Candidate

Study ID

NCT04494048

Start date

Apr 5, 2016

Status verified date

Apr, 2026

Completion date

Oct 31, 2035

Anticipated

Primary completion date

Oct 31, 2035

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Any patient who is considering undergoing EBT for weight loss within 6 months, or has undergone clinically indicated EBT for weight loss within the past 6 months
  • Above or equal to 18 years of age.

Exclusion Criteria:

  • Any patient who has not undergone or will undergo EBT for weight loss
  • Below 18 years of age.

Study Design

Enrollment

9999 participants

Anticipated

Interventions and Outcome Measures

Arms

Endoscopic Bariatric Therapies (EBT).

patients undergoing Endoscopic Bariatric Therapies

Interventions

Endoscopic Bariatric Therapies

Participation in this study will allow for data collection through medical chart review for at least 6 standard of care visits up to 1 year after consenting to participate in this registry study. The exposure of interest is total body weight loss, safety and efficacy

Primary outcome measure

  • Change of weight of the various bariatric therapies [ Time Frame: Baseline, 1 month, 6 months, and 1 year post procedure ]
  • Safety of procedure measured by in the number of adverse events of procedure [ Time Frame: at baseline ]
  • Safety of procedure measured by in the number of adverse events that occur within 30 days [ Time Frame: Within 30 days of the procedure ]

Central Contacts and Locations

Central contacts

Reem Z Sharaiha, MD, MSc.

646-962-2382rzs9001@med.cornell.edu

Andrea M Herr, NP

646-962-2382anb9057@med.cornell.edu

Locations

Weill Cornell Medicine

Recruiting

New York, New York, United States, 10021

Contacts

Reem Z Sharaiha, MD

6469622382rzs9001@med.cornell.edu

Andrea M Herr, NP

6469622382anb9057@med.cornell.edu

Principal Investigator:

Reem Z Sharaiha, MD

More Information

Sponsor

Weill Medical College of Cornell University

Last update posted

Apr 23, 2026

Last verified

Apr, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-07. This information was provided to ClinicalTrials.gov by Weill Medical College of Cornell University on 2026-04-23.